500 Years after What Might Have Been the Start of Modern Cardiology

500 years have passed since Leonardo da Vinci passed away (1452–1519), which is why we believe this is the perfect time to remember his passionate effort to study the human heart.

leonardo-da-vinci

Not only was Leonardo a gifted artist, but also an innovative engineer and inventor, a pioneer far ahead of his time. His scientific exploration of the human body, showing empirical power of observation and deduction, has made history and still echoes in modern biology.

His findings on the heart’s anatomy and its workings, documented in his notes and sketches, reveal the transition from occultism to modern cardiology.

At the time, the knowledge of human anatomy prevalent in Europe came mainly from Aristotle and Galen, who by the way had contradicting visions that were synthesized by Avicenna in Syria.


Read also: What Happens When We Are Blinded by Left Main Disease and Ignore All Other Lesions?


With the Renaissance in Italy, when the human body was emphasized as natural, for artists such as Leonardo the temptation to explore and experiment beyond the limits came along as naturally.

Leonardo was the first to note the heart’s beating quality and this fascinated him; “instrumento mirabile invenzionato dal sommo maestro” he called it, which translated from Italian means “the marvelous instrument invented by the Supreme Master”.

One of his dissections took place in 1506, at Santa Maria Nuova Hospital, in Florence. Leonardo dissected the body of a 100-year-old man in an attempt to understand his cause of death. Surprisingly, this dissection first describes heart disease and compares these findings with those of a 2-year-old dissection. The artist attributed the 100-year-old’s death to atherosclerosis.

After 500 years of Leonardo’s death, this article does not intend to summarize his life or his trajectory, but merely celebrate his genius.

Original Title: Leonardo da Vinci and his study of the Heart.

Reference: Marco Cambiaghi et al. European Heart Journal (2019) 40, 1823–1831.

Leonardo-da-Vinci-abierto

Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

TAVR in Small Annuli: What Valve Should We Use?

One of the major challenges of severe aortic stenosis are patients with small aortic annuli, defined as ≤430 mm² aortic valve area. This condition...

ACC 2025 | TAVI in Low-Risk Patients: 5-Year Outcomes of EVOLUTE LOW RISK

Transcatheter aortic valve implantation (TAVI) is a valid alternative to surgery in low-risk patients with severe aortic stenosis. However, one of its main limitations...

ACC 2025 | BHF PROTECT-TAVI: Are Cerebral Protection Systems Necessary in TAVI?

TAVI has seen a steady increase in use, though stroke continues to be one of its unwanted complications, mostly ischemic and, less frequently, hemorrhagic. The...

ACC-2025 Congress Second Day Key Studies

BHF PROTECT-TAVI (Kharbanda RK, Kennedy J, Dodd M, et al.)The largest randomized  trial carried out across 33 UK centers between 2020 and 2024, assessing...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

TAVR in Small Annuli: What Valve Should We Use?

One of the major challenges of severe aortic stenosis are patients with small aortic annuli, defined as ≤430 mm² aortic valve area. This condition...

Patients at High Risk of Bleeding After Coronary Angioplasty: Are Risk Assessment Tools ARC-HBR and PRECISE-DAPT Useful?

Patients undergoing coronary stenting typically receive dual antiplatelet therapy (DAPT) for 6 to 12 months, consisting of a P2Y12 receptor inhibitor and aspirin. While DAPT...

ACC 2025 | WARRIOR: Ischemia in Women with Non-Obstructive Coronary Artery Disease

Approximately half of all women with symptomatic ischemia who undergo coronary angiography are found to have non-obstructive coronary artery disease ((ischemia and non-obstructive coronary...